Vaccine Adjuvants Market Share, Industry Size, Opportunities, Analysis and Forecast To 2026
                     Vaccine Adjuvants Market 
Set to Exceed $1,305.7 Million By 2027 | CAGR 10.68%
“Vaccine Adjuvants Market Share, Size, Trends, Industry 
Analysis Report, By Product Type (Mineral Salt-based 
Adjuvant, Tensoactive Adjuvants, Adjuvant Emulsions, 
Liposome Adjuvants, Carbohydrate Adjuvants, Bacteria-
derived Adjuvants, Virus-like Particles (VLP), and Other 
Types); By Route of Administration (Oral, Subcutaneous, 
Intranasal, Intramuscular, Intradermal, and Others); By 
Disease Types; By Application (Research Application and 
Commercial Application), By Regions; Segment Forecast, 
2020 –2027”
Vaccine Adjuvants Market Estimate & Forecast to 2027
The global Vaccine Adjuvants Market size is expected to reach USD 1,305.7 million by 2027 
according to a new study by Polaris Market Research.
Adjuvant is defined as a substance which in combination with vaccine invigorates antigen 
specific immune reactions to increase specificity and immunogenicity of marketed vaccines 
administered in any individual. Adjuvants augment the impact of a vaccine providing 
increased immunity towards any particular infectious disease. It triggers positive immune 
response by mimicking pathogen associated molecular pattern (PAMP), which include lipo-
polysaccharide, liposomes, cell walls of bacteria, and endo-cytosed and un-methylated 
nucleic acids. Adjuvant imparts beneficial effects to vaccines in several ways such as 
increasing its potency to grasp the higher degree of immunogenicity, reducing the number 
of repeated vaccinations, antigen dose reduction, widening antibody responses of the 
individual, and inducing T-cell responses.
The global market is driven by the recent surge in infectious diseases, extensive research on 
vaccines, and funding from the government. European Union (EU) through EU programme 
Horizon 2020, has formed ENOVA, a network on vaccine adjuvants. This will bring both 
industry experts and stakeholders working in the areas of vaccine research and 
development and adjuvant research to reduce side effects and efficacy of new developing 
vaccines.
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 2
Vaccine Adjuvants Market Scope
By Product Type By Route of By Disease Type By Application By Region
Administrati
on
•Research Application •North America (U.S., Canada)
•Mineral Salt-based • Oral •Infectious Diseases •Commercial •Europe (Germany, UK, France, Italy, 
Adjuvant • Subcutaneo •Rare Diseases Application Spain)
•Tensoactive us •Cancer •Asia Pacific (China, India, Japan, South 
Adjuvants • Intranasal •Autoimmune Disorders Korea)
•Adjuvant • Intramuscul •Others •Latin America (Brazil, Mexico, 
Emulsions ar Colombia)
•Liposome • Intradermal •MEA (Saudi Arabia, South Africa, Israel, 
Adjuvants • Others UAE)
•Carbohydrate 
Adjuvants
•Bacteria-derived 
Adjuvants
•Virus-like Particles 
(VLP)
•Other Types           Request for sample
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 3
Vaccine Adjuvants Market Estimate & Forecast to 2027
Market participants such as GlaxoSmithKline Plc, Novavax, Inc., Statens Serum Institut, 
Viscogel AB, VaxLiant LLC, Aphios Corporation, Moderna Inc., Sanofi Pasteur, Adjuvatis, 
Avanti Polar Lipids, Inc., MPV Technologies, CSL Limited, Vaxine Pty Ltd, SPI Pharma, CureVac 
AG, Sergeant Adjuvants, Agenus, Inc., OZ Biosciences, Adjuvants Unlimited Inc., and 
Adjuvants Euclid Canada Inc. are some of the key players operating in the concerned 
market.
Access Research Report On Vaccine Adjuvants Market 
To speed up the process of nCOV vaccine development big players are collaborating with 
industry stakeholders. In February 2020, GSK and Coalition for Epidemic Preparedness 
Innovations (CEPI) collaborated to ease the out nCOV vaccine development with GSK’s 
vaccine adjuvant platform for other players in vaccine development. Similarly, in March 
2020, iBio, a contract research organization (CRO) signed a definitive agreement with the 
Infectious Disease Research Institute (IDRI). The combination of iBio’s VLP antigen with the 
latter adjuvant expected to offer promising efficacy and safety characteristics.
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 4
Vaccine Adjuvants Market Size
Speak To Analyst 
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 5
Vaccine Adjuvants Market Study – Engagement Options
Buy Now – Click Here!
Buy now & have immediate access to premium insights
Purchase Report Sections – Click Here!
Regional analysis
Segmentation analysis
 Industry outlook
Competitive landscape
Speak To Analyst – Click Here!
Get your doubts clear
Schedule a call with our analyst before making any decision
Request For Sample Pages – Click Here!
Get free sample pages 
Understand report structure
Unmask data for validation
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 6
About Us
Polaris Market Research is a global market research and consulting company. The company 
specializes in providing exceptional market intelligence and in-depth business research services 
for our clientele spread across different enterprises. We at Polaris are obliged to e present across 
the industries of healthcare, technology, semi-conductors and chemicals among various other 
industries present around the world. 
We strive to provide our customers with updated information on innovative technologies, high 
growth markets, emerging business environments and latest business-centric applications, 
thereby helping them always to make informed decisions and leverage new opportunities. Adept 
with a highly competent, experienced and extremely qualified team of experts comprising SMEs, 
analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our 
customers.
 
Web: www.polarismarketresearch.com
Official Blog: http://polarismarketresearch.blogspot.com/ 
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 7
Thank You!
Contact Us :
Polaris Market Research
30 Wall Street
8th Floor, 
New York City, NY 10005,
United States
E mail Id: [email protected]
Phone: +1-646-568-9980